Novel Agent Reduces Bowel Movement Frequency in Carcinoid Syndrome

Fibrosis and carcinoid syndrome: from causation to future therapy

PDF] Update on Pathophysiology, Treatment, and Complications of Carcinoid Syndrome

Carcinoid Syndrome Diarrhea

Targeted Systemic Treatment of Neuroendocrine Tumors: Current

Management of Diarrhea in Patients With Carcinoid Syndrome. - Abstract - Europe PMC

The role of serotonin inhibition within the treatment of carcinoid syndrome in: Endocrine Oncology Volume 3 Issue 1 (2023)

Frontiers Biomarkers for Pancreatic Neuroendocrine Neoplasms (PanNENs) Management—An Updated Review

Safety, tolerability, pharmacokinetics, and pharmacodynamics of a long-acting release (LAR) formulation of pasireotide (SOM230) in patients with gastroenteropancreatic neuroendocrine tumors: results from a randomized, multicenter, open-label, phase I

Cancers, Free Full-Text

JCM, Free Full-Text

PDF) What Gastroenterologists Should Know about Carcinoid Syndrome

Diagnosing and Managing Carcinoid Heart Disease in Patients With Neuroendocrine Tumors: An Expert Statement - ScienceDirect